Xenon to Present at Wells Fargo Healthcare Conference
Xenon Pharmaceuticals will host a webcast fireside chat at the Wells Fargo Healthcare Conference, with replay access available for investors after the event.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xenon Pharmaceuticals (XENE) plans to present at the Wells Fargo Healthcare Conference in Boston, MA, via a fireside chat scheduled for Wednesday, September 9, from 11:00 to 11:30 am ET.
Details and a live webcast link will be available in the Investors section of Xenon’s website, with a replay posted after the event, subject to possible schedule changes.
Details
News Market Reaction – XENE
On Sep 4, the first trading day after this news, XENE closed 1.08% below the previous close.
Data tracked by StockTitan Argus for the Sep 4 session.
Key Figures
- Announcement Date
- September 3, 2026
- News announcement
- Conference Date
- September 9
- Wells Fargo Healthcare Conference
- Fireside Chat Time
- 11:00–11:30 am ET
- September 9 presentation
- Development Stage
- Phase 1
- Early-stage potassium and sodium channel modulator programs
Historical Context
-
Equity awards granted to five new non-officer employees under Nasdaq rules.
-
Company announced upcoming Phase 3 epilepsy data and additional scientific presentations.
-
Quarterly report included no revenue, a net loss, and ongoing development updates.
-
Equity awards granted to eleven new non-officer employees under Nasdaq rules.
-
Company scheduled its Q2 2026 financial-results release and business update.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
kv7 potassium channel opener technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC and BOSTON, MA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at an upcoming investor conference:
- Wells Fargo Healthcare Conference, Boston, MA
Fireside Chat: Wednesday, September 9, 11:00–11:30 am ET
Details about the presentation, including webcast information, can be found on the Investors section of Xenon's website. When available, webcasts are posted for replay following the event. The above-listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Xenon’s lead molecule, azetukalner, is a novel, potent KV7 potassium channel opener in late-stage clinical development for the treatment of epilepsy, major depressive disorder and bipolar depression. Xenon is also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including KV7 and NaV1.7 programs in Phase 1 development for the potential treatment of pain. Xenon has offices in Vancouver, British Columbia, and Boston, Massachusetts. For more information, visit www.xenon-pharma.com and follow us on LinkedIn and X.
Xenon and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in the US, Canada and elsewhere. All other trademarks belong to their respective owner.
Contacts:
For Investors:
Tucker Kelly
Chief Financial Officer
investors@xenon-pharma.com
For Media:
Colleen Alabiso
Senior Vice President, Corporate Affairs
media@xenon-pharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Xenon Pharmaceuticals (XENE) present at the Wells Fargo Healthcare Conference?
Xenon Pharmaceuticals is scheduled to present at the Wells Fargo Healthcare Conference in Boston, MA, on Wednesday, September 9, during a fireside chat from 11:00 to 11:30 am ET, although the company notes that dates and times are subject to change.
How can investors access the Xenon Pharmaceuticals (XENE) Wells Fargo Healthcare Conference webcast?
Webcast details for Xenon Pharmaceuticals’ fireside chat at the Wells Fargo Healthcare Conference will be available in the Investors section of the company’s website, where a replay will also be posted after the event when available.
Will a replay of Xenon Pharmaceuticals (XENE) Wells Fargo Healthcare Conference presentation be available?
Yes. Xenon Pharmaceuticals indicates that webcasts of its Wells Fargo Healthcare Conference presentation will be posted for replay following the event in the Investors section of its website, once available.
Where is Xenon Pharmaceuticals (XENE) headquartered and what is its therapeutic focus?
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company with offices in Vancouver, British Columbia, and Boston, Massachusetts. It is dedicated to drug discovery, clinical development, and commercialization of therapeutics targeting epilepsy, mood disorders, and pain.